<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2010-02-15 07:54:39Epidemiology Drug discovery Clinical research Pharmacology Pharmaceutical industry Orphan drug Rare disease Genetic Alliance UK National Institute for Health and Clinical Excellence Health Pharmaceutical sciences Medicine |
|
Consultation Response Innovation Pass Pilot Department of Health Response by the Genetic Interest Group and Rare Disease UK The Genetic Interest Group (GIG) is the UK national alliance for all people affected by genetic